{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:09:02Z","timestamp":1790680142809,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/3\/JRF-2012\/HRD-08(10835)"],"award-info":[{"award-number":["3\/1\/3\/JRF-2012\/HRD-08(10835)"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00408-020-00320-x","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T13:02:36Z","timestamp":1578574956000},"page":"377-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of Serum TGF-\u03b21 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation"],"prefix":"10.1007","volume":"198","author":[{"given":"Swati","family":"Sagwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-2743","authenticated-orcid":false,"given":"Meenu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manvi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"issue":"1","key":"320_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1183\/09031936.03.00057003","volume":"23","author":"RC Boucher","year":"2004","unstructured":"Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23(1):146\u2013158","journal-title":"Eur Respir J"},{"issue":"22","key":"320_CR2","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJM199011293232203","volume":"323","author":"E Kerem","year":"1990","unstructured":"Kerem E, Corey M, Kerem B et al (1990) The relation between genotype and phenotype in cystic fibrosis\u2014analysis of the most common mutation (\u0394F508). N Engl J Med 323(22):1517\u20131522","journal-title":"N Engl J Med"},{"issue":"14","key":"320_CR3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMoa051469","volume":"353","author":"ML Drumm","year":"2005","unstructured":"Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F et al (2005) Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353(14):1443\u20131453","journal-title":"N Engl J Med"},{"issue":"14","key":"320_CR4","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/hmg\/ddn123","volume":"17","author":"LA Bremer","year":"2008","unstructured":"Bremer LA, Blackman SM, Vanscoy LL, McDougal KE, Bowers A, Naughton KM et al (2008) Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum Mol Genet 17(14):2228\u20132237","journal-title":"Hum Mol Genet"},{"issue":"8","key":"320_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/thx.49.8.789","volume":"49","author":"A Magnan","year":"1994","unstructured":"Magnan A, Frachon I, Rain B, Peuchmaur M, Monti G, Lenot B et al (1994) Transforming growth factor \u03b2 in normal human lung: preferential location in bronchial epithelial cells. Thorax 49(8):789\u2013792","journal-title":"Thorax"},{"issue":"2","key":"320_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","volume":"85","author":"KC Flanders","year":"2004","unstructured":"Flanders KC (2004) Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85(2):47\u201364","journal-title":"Int J Exp Pathol"},{"issue":"6","key":"320_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1136\/thorax.55.6.459","volume":"55","author":"PD Arkwright","year":"2000","unstructured":"Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK et al (2000) TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 55(6):459\u2013462","journal-title":"Thorax"},{"issue":"14","key":"320_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMe058185","volume":"353","author":"CK Haston","year":"2005","unstructured":"Haston CK, Hudson TJ (2005) Finding genetic modifiers of cystic fibrosis. N Engl J Med 353(14):1509\u20131511","journal-title":"N Engl J Med"},{"issue":"11","key":"320_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/ppul.21079","volume":"44","author":"WT Harris","year":"2009","unstructured":"Harris WT, Muhlebach MS, Oster RA et al (2009) Transforming growth factor-beta(1) inbronchoalveolar lavage fluid from children with cystic fibrosis. Pediatr Pulmonol 44(11):1057\u20131064","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"320_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/ppul.21430","volume":"46","author":"WT Harris","year":"2011","unstructured":"Harris WT, Muhlebach MS, Oster RA, Knowles MR, Clancy JP, Noah TL (2011) Plasma TGF-\u03b2(1) in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy. Pediatric Pulmonol 46(7):688\u2013695","journal-title":"Pediatric Pulmonol"},{"issue":"2","key":"320_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00005176-200308000-00019","volume":"37","author":"KB Schwarz","year":"2003","unstructured":"Schwarz KB, Rosensweig J, Sharma S, Jones L, Durant M, Potter C, Narkewicz MR (2003) Plasma markers of platelet activation in cystic fibrosis liver and lung disease. J Pediatric Gastroenterol Nutr 37(2):187\u2013191","journal-title":"J Pediatric Gastroenterol Nutr"},{"issue":"5","key":"320_CR12","doi-asserted-by":"publisher","first-page":"e63167","DOI":"10.1371\/journal.pone.0063167","volume":"8","author":"SM Snodgrass","year":"2013","unstructured":"Snodgrass SM, Cihil KM, Cornuet PK, Myerburg MM, Swiatecka-Urban A (2013) Tgf-b1 inhibits Cftr biogenesis and prevents functional rescue of \u0394F508-Cftr in primary differentiated human bronchial epithelial cells. PLoS ONE 8(5):e63167","journal-title":"PLoS ONE"},{"key":"320_CR13","doi-asserted-by":"publisher","first-page":"e106842","DOI":"10.1371\/journal.pone.0106842","volume":"9","author":"H Sun","year":"2014","unstructured":"Sun H et al (2014) Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia. PLoS ONE 9:e106842","journal-title":"PLoS ONE"},{"key":"320_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/MCP.0b013e3283121cdc","volume":"14","author":"JM Collaco","year":"2008","unstructured":"Collaco JM, Cutting GR (2008) Update on gene modifiers in cysticfibrosis. Curr Opin Pulm Med 14:559\u2013566","journal-title":"Curr Opin Pulm Med"},{"key":"320_CR15","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/S1569-1993(11)60012-X","volume":"10","author":"D Bilton","year":"2011","unstructured":"Bilton D, Canny G, Conway S et al (2011) Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros 10:S79\u2013S81","journal-title":"J Cyst Fibros"},{"issue":"3","key":"320_CR16","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1086\/376525","volume":"37","author":"DA Stevens","year":"2003","unstructured":"Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA et al (2003) Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2014state of the art: cystic fibrosis foundation consensus conference. Clin Infect Dis 37(3):S225\u2013S264","journal-title":"Clin Infect Dis"},{"key":"320_CR17","first-page":"149","volume":"5","author":"RM Ferrie","year":"1992","unstructured":"Ferrie RM, Schwarz MJ, Robertson NH, (1992) Development, multiplexing and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet 5:149\u2013155","journal-title":"Am J Hum Genet"},{"key":"320_CR18","doi-asserted-by":"publisher","first-page":"913135","DOI":"10.1155\/2013\/913135","volume":"2013","author":"O Eickmeier","year":"2013","unstructured":"Eickmeier O, Boom L, Schreiner F, Lentze MJ, NGampolo D, Schubert R, et al (2013) Transforming growth factor \u03b21 genotypes in relation to TGF\u03b21, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosis. Med Inflamm 2013:913135","journal-title":"Med Inflamm"},{"issue":"12","key":"320_CR19","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/ppul.20935","volume":"43","author":"HBP Corvol","year":"2008","unstructured":"Corvol HBP, Brouard J, Knauer N, Chadelat K, Henrion-Caude A, Flamant C et al (2008) Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis. Pediatr Pulmonol 43(12):1224\u20131232","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"320_CR20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.26719\/2001.7.6.975","volume":"7","author":"KP Dawson","year":"2001","unstructured":"Dawson KP, Frossard PM, Al-Awar B (2001) Disease severity associated with cysticfibrosis mutations deltaF508 and S549R(T\u2013%3eG). East Mediterr Health J 7(6):975\u2013980","journal-title":"East Mediterr Health J"},{"issue":"19","key":"320_CR21","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.3390\/ijms20194933","volume":"20","author":"N Mitash","year":"2019","unstructured":"Mitash N, Mu F, Donovan JE, Myerburg MM, Ranganathan S, Greene CM, Swiatecka-Urban A (2019) Transforming growth factor-\u03b21 selectively recruits microRNAto the RNA-induced silencing complex and degrades CFTR mRNA under permissive conditions in human bronchial epithelial cells. Int J Mol Sci 20(19):4933","journal-title":"Int J Mol Sci"},{"issue":"2","key":"320_CR22","doi-asserted-by":"publisher","first-page":"S278","DOI":"10.1016\/j.jaci.2004.01.476","volume":"113","author":"AP Knutsen","year":"2019","unstructured":"Knutsen AP et al (2019) T cell cytokine synthesis in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 113(2):S278","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"320_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00408-016-9925-9","volume":"194","author":"JP Maloney","year":"2019","unstructured":"Maloney JP, Narasimhan J, Biller J (2019) Decreased TGF-\u03b21 and VEGF release in cystic fibrosis platelets: further evidence for platelet defects in cystic fibrosis. Lung 194(5):791\u2013798","journal-title":"Lung"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00320-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-020-00320-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00320-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T16:58:33Z","timestamp":1665421113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-020-00320-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1007\/s00408-020-00320-x","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}